Cardioprotection strategies for anthracycline cardiotoxicity

2024-9-9

Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients

2024-9-3

Cardioprotection of voluntary exercise against breast cancer-induced cardiac injury via STAT3

2024-8-19

β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia–reperfusion injury

2024-8-12

Proprioceptors of the human pericardium

2024-8-9

Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca2+ channel

2024-8-7

Recombinant human placental growth factor-2 in post-infarction left ventricular dysfunction: a randomized, placebo-controlled, preclinical study

2024-8-1

SGLT1 contributes to glucose-mediated exacerbation of ischemia–reperfusion injury in ex vivo rat heart

2024-8-1

Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2

2024-7-24

Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy

2024-7-22

Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors

2024-7-17

The attenuated hepatic clearance of propionate increases cardiac oxidative stress in propionic acidemia

2024-7-11

Bone marrow cells contribute to seven different endothelial cell populations in the heart

2024-7-4

Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond

2024-6-27

Increased [18F]FDG uptake in the infarcted myocardial area displayed by combined PET/CMR correlates with snRNA-seq-detected inflammatory cell invasion

2024-6-26

Mitochondrial calcium in cardiac ischemia/reperfusion injury and cardioprotection

2024-6-19

Gasotransmitters and noble gases in cardioprotection: unraveling molecular pathways for future therapeutic strategies

2024-6-15

Malonate given at reperfusion prevents post-myocardial infarction heart failure by decreasing ischemia/reperfusion injury

2024-6-12

Cardioprotection in cardiovascular surgery

2024-6-10

Heart-specific NFAT5 knockout suppresses type I interferon signaling and aggravates coxsackievirus-induced myocarditis

2024-6-5

Targeting Gαi2 in neutrophils protects from myocardial ischemia reperfusion injury

2024-5-30

Vasodilator reactive oxygen species ameliorate perturbed myocardial oxygen delivery in exercising swine with multiple comorbidities

2024-5-25

Chronic kidney disease activates the HDAC6-inflammatory axis in the heart and contributes to myocardial remodeling in mice: inhibition of HDAC6 alleviates chronic kidney disease-induced myocardial remodeling

2024-5-21

Comparison of the stage-dependent mitochondrial changes in response to pressure overload between the diseased right and left ventricle in the rat

2024-5-17

The role and mechanism of epigenetics in anticancer drug-induced cardiotoxicity

2024-5-9

Connexin 43 modulates reverse electron transfer in cardiac mitochondria from inducible knock-out Cx43Cre−ER(T)/fl mice by altering the coenzyme Q pool

2024-5-9

Unveiling cellular and molecular aspects of ascending thoracic aortic aneurysms and dissections

2024-5-3

Targeting cardiomyocyte cell cycle regulation in heart failure

2024-4-29

“Expression of concern”: publication bias for positive preclinical cardioprotection studies

2024-4-26

Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival

2024-4-19

Dapagliflozin and atrial fibrillation: elevated dosing to achieve class I antiarrhythmic effects?

2024-4-3

Exercise training decreases lactylation and prevents myocardial ischemia–reperfusion injury by inhibiting YTHDF2

2024-4-2

Role of inflammatory signaling pathways involving the CD40–CD40L–TRAF cascade in diabetes and hypertension—insights from animal and human studies

2024-3-30

Metabolic changes contribute to maladaptive right ventricular hypertrophy in pulmonary hypertension beyond pressure overload: an integrative imaging and omics investigation

2024-3-27

Insulin and glycolysis dependency of cardioprotection by nicotinamide riboside

2024-3-25

Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin

2024-3-23

Identification of a mechanism promoting mitochondrial sterol accumulation during myocardial ischemia–reperfusion: role of TSPO and STAR

2024-3-22

Oxidation–reduction imaging of myoglobin reveals two-phase oxidation in the reperfused myocardium

2024-3-18

Characterizing the immune response to myocardial infarction in pigs

2024-3-15

Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging

2024-3-14

Pathophysiology and clinical relevance of atrial myopathy

2024-3-12

Role of CD4+ T-cells for regulating splenic myelopoiesis and monocyte differentiation after experimental myocardial infarction

2024-3-4

Crosstalk of human coronary perivascular adipose-derived stem cells with vascular cells: role of tissue factor

2024-3-2

Exercise, cancer, and the cardiovascular system: clinical effects and mechanistic insights

2024-2-14

Distinct cytoskeletal regulators of mechanical memory in cardiac fibroblasts and cardiomyocytes

2024-2-13

The interplay of collagen, macrophages, and microcalcification in atherosclerotic plaque cap rupture mechanics

2024-2-8

Mineralocorticoid receptor promotes cardiac macrophage inflammaging

2024-2-8

Statins affect human iPSC-derived cardiomyocytes by interfering with mitochondrial function and intracellular acidification

2024-2-2

Macrophage profiling in atherosclerosis: understanding the unstable plaque

2024-1-20

Lysophosphatidic acid contributes to myocardial ischemia/reperfusion injury by activating TRPV1 in spinal cord

2024-1-18